M G Netea1, B J Kullberg, J W M van der Meer. 1. Radboud University Medical Centre and Nijmegen University Center for Infectious Diseases, Nijmegen, the Netherlands.
Abstract
BACKGROUND: Hyperimmunoglobulin E syndrome (HIES) is an inborn disorder characterized by recurrent skin and respiratory tract infections, skeletal abnormalities, chronic eczema and elevated serum IgE. The nature of the host defence defect has yet to be established. The aim of this study was to investigate whether activation of the interleukin-12/interleukin-18/interferon-gamma axis, known to be crucial for the activation of cellular immune responses, is impaired in patients with HIES. MATERIALS AND METHODS: Cytokine production capacity of seven HIES patients and seven healthy controls was investigated in whole-blood cultures stimulated with heat-killed Staphylococcus aureus, Candida albicans, or a combination of interleukin (IL)-12/IL-18. RESULTS: Interferon (IFN)gamma production, in addition to IFNgamma/IL-10 ratios, was 10-30-fold lower in the HIES patients compared with the healthy volunteers. In contrast TNF, IL-1beta and IL-8 production was normal. CONCLUSIONS: These data revealed a severe dysbalance towards a Th2 phenotype in HIES patients which is likely to contribute to the specific pattern of infection susceptibility characteristic to HIES.
BACKGROUND: Hyperimmunoglobulin E syndrome (HIES) is an inborn disorder characterized by recurrent skin and respiratory tract infections, skeletal abnormalities, chronic eczema and elevated serum IgE. The nature of the host defence defect has yet to be established. The aim of this study was to investigate whether activation of the interleukin-12/interleukin-18/interferon-gamma axis, known to be crucial for the activation of cellular immune responses, is impaired in patients with HIES. MATERIALS AND METHODS: Cytokine production capacity of seven HIESpatients and seven healthy controls was investigated in whole-blood cultures stimulated with heat-killed Staphylococcus aureus, Candida albicans, or a combination of interleukin (IL)-12/IL-18. RESULTS: Interferon (IFN)gamma production, in addition to IFNgamma/IL-10 ratios, was 10-30-fold lower in the HIESpatients compared with the healthy volunteers. In contrast TNF, IL-1beta and IL-8 production was normal. CONCLUSIONS: These data revealed a severe dysbalance towards a Th2 phenotype in HIESpatients which is likely to contribute to the specific pattern of infection susceptibility characteristic to HIES.
Authors: F L van de Veerdonk; R J Marijnissen; R Marijnissen; L A B Joosten; B J Kullberg; J P H Drenth; M G Netea; J W M van der Meer Journal: Clin Exp Immunol Date: 2009-10-30 Impact factor: 4.330
Authors: Jaap Ten Oever; Frank L van de Veerdonk; Leo A B Joosten; Anna Simon; Reinout van Crevel; Bart-Jan Kullberg; Inge C Gyssens; Jos W M van der Meer; Marcel van Deuren; Mihai G Netea Journal: Clin Vaccine Immunol Date: 2014-05-28
Authors: Cristina Woellner; E Michael Gertz; Alejandro A Schäffer; Macarena Lagos; Mario Perro; Erik-Oliver Glocker; Maria C Pietrogrande; Fausto Cossu; José L Franco; Nuria Matamoros; Barbara Pietrucha; Edyta Heropolitańska-Pliszka; Mehdi Yeganeh; Mostafa Moin; Teresa Español; Stephan Ehl; Andrew R Gennery; Mario Abinun; Anna Breborowicz; Tim Niehues; Sara Sebnem Kilic; Anne Junker; Stuart E Turvey; Alessandro Plebani; Berta Sánchez; Ben-Zion Garty; Claudio Pignata; Caterina Cancrini; Jiri Litzman; Ozden Sanal; Ulrich Baumann; Rosa Bacchetta; Amy P Hsu; Joie N Davis; Lennart Hammarström; E Graham Davies; Efrem Eren; Peter D Arkwright; Jukka S Moilanen; Dorothee Viemann; Sujoy Khan; László Maródi; Andrew J Cant; Alexandra F Freeman; Jennifer M Puck; Steven M Holland; Bodo Grimbacher Journal: J Allergy Clin Immunol Date: 2010-02 Impact factor: 10.793
Authors: Netanya S Utay; Annelys Roque; J Katherina Timmer; David R Morcock; Claire DeLeage; Anoma Somasunderam; Amy C Weintrob; Brian K Agan; Jacob D Estes; Nancy F Crum-Cianflone; Daniel C Douek Journal: PLoS Pathog Date: 2016-04-19 Impact factor: 6.823